Skip to main content
. 2020 Jul 8;11:1461. doi: 10.3389/fmicb.2020.01461

FIGURE 9.

FIGURE 9

A proposed signaling pathway involved in SeMet against ESBL E. coli-induced inflammation. Note that SeMet protects bMECs and macrophages against inflammation by inhibition of TLR4/NF-κB signaling pathway. Meanwhile, SeMet suppressed NF-κB pathway through SeS and inhibited NF-κB-reduced inflammation. Green arrow and red bar indicate stimulation and inhibition, respectively.